The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Results of a phase II, open-label pilot study evaluating the safety and activity of liposomal irinotecan (Nal-IRI) in combination with 5-FU and oxaliplatin (NALIRIFOX) in preoperative treatment of pancreatic adenocarcinoma (NEO-Nal-IRI study).
 
Thomas J. George
Consulting or Advisory Role - BillionToOne; Seagen; Tempus
Research Funding - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca/MedImmune (Inst); Bayer (Inst); BillionToOne (Inst); BioMed Valley Discoveries (Inst); Bristol-Myers Squibb (Inst); Elicio Therapeutics (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Ipsen (Inst); Jounce Therapeutics (Inst); Lilly (Inst); Merck (Inst); OncoC4 (Inst); Seagen (Inst)
 
Sherise C. Rogers
Consulting or Advisory Role - Natera
 
Ibrahim Nassour
No Relationships to Disclose
 
Ilyas Sahin
No Relationships to Disclose
 
Brian Hemendra Ramnaraign
Consulting or Advisory Role - Cardinal Health; Ipsen; Merck; Pfizer
 
Jesus Fabregas
Consulting or Advisory Role - Ipsen
Speakers' Bureau - AstraZeneca
Research Funding - Bristol-Myers Squibb
 
Kathryn Hitchcock
Research Funding - Merck; Naveris
Other Relationship - Elekta; Medtronic
(OPTIONAL) Uncompensated Relationships - MVision; Philips Healthcare
 
Tuo Lin
No Relationships to Disclose
 
Gonghao Liu
No Relationships to Disclose
 
Robert Zlotecki
No Relationships to Disclose
 
Omar Roger Kayaleh
No Relationships to Disclose
 
Anita Ahmed Turk
Consulting or Advisory Role - KLM Solutions
Research Funding - Lilly (Inst); Merck
 
Z. Hugh Fan
No Relationships to Disclose
 
Karen Bullock Russell
No Relationships to Disclose
 
David L. DeRemer
Leadership - Hematology/Oncology Pharmacy Association
Consulting or Advisory Role - Bristol Myers Squibb
 
Ji-Hyun Lee
No Relationships to Disclose
 
Steven J. Hughes
Research Funding - Merck